Pustular Psoriasis – Market outlook, Epidemiology, Competitive Landscape and Market Forecast Report – 2020 To 2030
Pustular psoriasis is a rare, immune-mediated systemic skin disorder characterized by yellowish pustules on an erythematous base with a variety of clinical presentations and distribution patterns. Etiology- Patients with pustular psoriasis have an increased frequency of the HLA-B27 allele compared to the general population. Most cases of pustular psoriasis are idiopathic. Epidemiology- Generalized pustular psoriasis is rare. The annual incidence and prevalence in a French population have been estimated at least 0.64 and 1.76 per million, respectively. The prevalence in Japan has been estimated at 7.46 per million. The competitive landscape of Pustular Psoriasis includes country-specific approved and pipeline therapies. Any asset/product-specific designation or review and Accelerated Approval are tracked and supplemented with analyst commentary. KOLs insights of Pustular Psoriasis across 8 MM market from the center of Excellence/ Public/ Private hospitals participated in the study. Ins...